Drug-induced seizures are a significant complication in drug development. While the electroencephalogram (EEG) is clinically translatable and is the gold standard for assessing a drug’s seizure liability, the analysis and use of the tool differs widely between clinical and preclinical practices. A combination of expert-driven and computerized toolbox-aided EEG analysis approaches can yield the best results. Learn more about these strategies by registering for this free webinar.
(PRWeb June 04, 2019)
Read the full story at https://www.prweb.com/releases/best_practices_for_eeg_analyses_in_nonclinical_seizure_liability_studies_upcoming_webinar_hosted_by_xtalks/prweb16351915.htm
For more information, please visit
https://www.prweb.com/releases/best_prac[...]ed_by_xtalks/prweb16351915.htm